Skip to content
Open Palace

Providing Stem Cells During Pregnancy to Babies with Spina Bifida Boosts Life Outcomes, Research Shows

A groundbreaking research effort has found that administering stem cells to fetuses affected by spina bifida during corrective surgery could constitute a "important advancement" in managing prenatal disorders.

Research Framework and Assurance

The research conducted in the United States focused on six fetuses with a severe neural tube defect. Doctors administered regenerative cells sourced from the maternal placenta directly onto the baby's spinal cord while the defect was being closed.

Importantly, the regenerative treatment demonstrated a favorable safety profile. The study team reported that the treatment did not lead to neoplasms, disrupt the healing process, or prevent the reversal of co-occurring hindbrain herniation.

Encouraging Results

Magnetic resonance imaging performed on the newborns indicated a successful correction of hindbrain herniation in all six infants. This neurological improvement is closely linked to improved motor skills and quality of life.

"If it makes more children to achieve ambulation who wouldn't have, then it would become their standard of care," noted the study director. "The outcomes appear super exciting and open the door to a variety of prospective innovative interventions."

Broader Impact and Encouragement

Commentators reviewing the findings proposed that further confirmation of these observed advantages could signal a "different age" in in-utero treatment. The possibility of ameliorating nerve function impairment present before birth is regarded as a paradigm-shifting aim.

Notably important would be improvements in urogenital and gastrointestinal outcomes, which are common challenges for people affected by this condition.

Future Directions

Despite this being a first-in-human effort focused on a handful of cases, its safety demonstration and positive signals create a solid basis for broader investigative efforts. The integration of stem cell therapy with current in-utero repair procedures holds considerable promise for changing life trajectories for babies yet to be born with this neural tube defect.

Written by

Joseph Little

A Toronto-based architect with over 15 years of experience specializing in sustainable residential projects across Ontario.

Open Palace

Type to search articles.